Home › NDC Lookup › RxCUI directory › RxCUI 722116

Ambrisentan 10 MG Oral Tablet — RxCUI 722116

Name: Ambrisentan 10 MG Oral Tablet (RxCUI 722116)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 722116 Semantic clinical drug · SCD ● Current RxNorm concept 25 FDA products 59 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI722116

Official nameAmbrisentan 10 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped25

Package NDCs mapped59

Reported Medicaid activity (SDUD)21,600 prescriptions · 45 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ambrisentan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Ambrisentan won't cure PAH, but it can make a real difference in how you feel and function. It works by blocking a protein called ET-1 that causes the blood vessels in your lungs t...
What exactly does ambrisentan do, and will it cure my PAH?
Good news — food doesn't affect how well your body absorbs ambrisentan, so you can take it with or without a meal, whichever works best for your routine. Pick a time of day you can...
Can I take ambrisentan with food, and does it matter what time of day I take it?

📖 Read our full Ambrisentan guide →

🕸️ Concept Web — How Ambrisentan 10 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Ambrisentan 10 MG Oral Tablet RxCUI 722116 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Ambrisentan 358274 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Letairis 722117 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Ambrisentan Oral Tablet 722115 SCDF
- Ambrisentan Oral Product 1157135 SCDG
- Ambrisentan Pill 1157136 SCDG
- Ambrisentan Oral Tablet [Letairis] 722119 SBDF
- Letairis Oral Product 1166063 SBDG
- Letairis Pill 1166064 SBDG
- Oral Tablet 317541 DF
- Oral Product 1151131 DFG
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Ambrisentan 10 MG 722114 SCDC
- Ambrisentan 10 MG Oral Tablet [Letairis] 722120 SBD
- Ambrisentan 10 MG [Letairis] 722118 SBDC

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Ambrisentan 10 MG SCDC · 722114
Ambrisentan Oral Tablet SCDF · 722115
Ambrisentan Oral Product SCDG · 1157135
Ambrisentan Pill SCDG · 1157136

Brand-Name Concepts

Ambrisentan 10 MG Oral Tablet [Letairis] SBD · 722120
Ambrisentan 10 MG [Letairis] SBDC · 722118
Ambrisentan Oral Tablet [Letairis] SBDF · 722119
Letairis Oral Product SBDG · 1166063
Letairis Pill SBDG · 1166064
Letairis BN · 722117

📦 FDA Products & Package NDCs

25 products · 59 package NDCs

59 package NDCs map to RxCUI 722116 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
70771-1363-08	3 BLISTER PACK in 1 CARTON (70771-1363-8) / 10 TABLET, FILM...	Ambrisentan	Zydus Lifesciences Limited	2019-04-12
70771-1363-09	90 TABLET, FILM COATED in 1 BOTTLE (70771-1363-9)	Ambrisentan	Zydus Lifesciences Limited	2019-04-12
70771-1364-01	100 TABLET, FILM COATED in 1 BOTTLE (70771-1364-1)	Ambrisentan	Zydus Lifesciences Limited	2019-04-12
70771-1364-03	30 TABLET, FILM COATED in 1 BOTTLE (70771-1364-3)	Ambrisentan	Zydus Lifesciences Limited	2019-04-12
70771-1364-07	1 BLISTER PACK in 1 CARTON (70771-1364-7) / 10 TABLET, FILM...	Ambrisentan	Zydus Lifesciences Limited	2019-04-12
70771-1364-08	3 BLISTER PACK in 1 CARTON (70771-1364-8) / 10 TABLET, FILM...	Ambrisentan	Zydus Lifesciences Limited	2019-04-12
70771-1364-09	90 TABLET, FILM COATED in 1 BOTTLE (70771-1364-9)	Ambrisentan	Zydus Lifesciences Limited	2019-04-12
82009-0141-30	30 TABLET, FILM COATED in 1 BOTTLE (82009-141-30)	Ambrisentan	Quallent Pharmaceuticals Health LLC	2024-05-01
82009-0142-30	30 TABLET, FILM COATED in 1 BOTTLE (82009-142-30)	Ambrisentan	Quallent Pharmaceuticals Health LLC	2024-05-01

Observed labelers: Gilead Sciences, Inc. (10) · Zydus Lifesciences Limited (10) · Zydus Pharmaceuticals USA Inc. (10) · Sun Pharmaceutical Industries, Inc. (8) · Cipla USA Inc. (4) · Sigmapharm Laboratories, LLC (4) · +7 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.